PPARGC1B and breast cancer: Given the known modification of ER activity by PPARGC1B in cellular response to estrogen exposure, we investigated the genetic interaction between rs741581, rs2340621 and rs6895698 within PPARGC1B and rs7761846 within ESR1 in terms of modulating ER-positive breast cancer risk.